We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

A Milestone Is Reached For New Leukemia Drug

News   Nov 20, 2019 | Original story from Cold Spring Harbor Laboratory

 
A Milestone Is Reached For New Leukemia Drug

Bioluminescence imaging of mice whose cancer cells were tagged with a firefly-derived enzyme shows how the drug YKL-05-099 blocks the SIK3 pathway to slow the progression of leukemia. Credit: Vakoc lab/CSHL, 2019.

 
 
Advertisement
 

RELATED ARTICLES

Mass Spectrometrists Around the World Pull Together To Share COVID-19 Data

News

A new coalition of more than 500 scientists from around the world has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

READ MORE

Funding Awarded to COVID-19 Clinical Study Targeting Angiotensin Receptor

News

UK charity LifeArc has awarded Vicore Pharma approximately £1.5 million for the ATTRACT VP01 (C21) COVID-19 study.

READ MORE

DNA Analysis From Ancient Bronze Age Individuals

News

A new study has found that the DNA of Canaanites is a mixture of two populations: The Chalcolithic Zagros and Early Bronze Age Caucasus.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE